Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Adults

NCT01466387 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01466387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01466387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Adults
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2011
Completion date
April 30, 2012
Enrollment
552 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

japanese encephalitis, meningococcal disease, meningococcal meningitis, rabies, typhoid, yellow fever